BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32078043)

  • 1. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
    Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
    Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
    Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
    Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
    Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases.
    de Saint Aubain Somerhausen N; Fletcher CD
    Am J Surg Pathol; 1999 Jul; 23(7):755-63. PubMed ID: 10403297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid leiomyosarcoma of soft tissue, an underrecognized variant.
    Rubin BP; Fletcher CD
    Am J Surg Pathol; 2000 Jul; 24(7):927-36. PubMed ID: 10895815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity.
    Chang A; Schuetze SM; Conrad EU; Swisshelm KL; Norwood TH; Rubin BP
    Int J Surg Pathol; 2005 Apr; 13(2):185-95. PubMed ID: 15864383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
    Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
    Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors.
    Mentzel T; Dry S; Katenkamp D; Fletcher CD
    Am J Surg Pathol; 1998 Oct; 22(10):1228-38. PubMed ID: 9777985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma.
    Gómez JA; Amin MB; Ro JY; Linden MD; Lee MW; Zarbo RJ
    Arch Pathol Lab Med; 1999 Jun; 123(6):503-7. PubMed ID: 10383802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of A Low-Grade Inflammatory Leiomyosarcoma/Histiocyte-Rich Rhabdomyoblastic Tumor in the Neck of An Adolescent Male.
    Rekhi B; Bal M; Dharavath B; Dutt A; Pai P
    Turk Patoloji Derg; 2023; 39(2):154-160. PubMed ID: 35642345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.
    Arbajian E; Köster J; Vult von Steyern F; Mertens F
    Mod Pathol; 2018 Jan; 31(1):93-100. PubMed ID: 28884746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Rhabdomyoblastic Tumor: From a Nebulous Smooth Muscle Neoplasm to a Novel Skeletal Muscle Tumor Subtype.
    Michal M
    Surg Pathol Clin; 2024 Mar; 17(1):65-76. PubMed ID: 38278608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
    Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms.
    Martinez AP; Fritchie KJ; Weiss SW; Agaimy A; Haller F; Huang HY; Lee S; Bahrami A; Folpe AL
    Mod Pathol; 2019 Mar; 32(3):446-457. PubMed ID: 30287926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.